BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7477118)

  • 21. Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results.
    Bacci G; Avella M; Brach Del Prevert A; Capanna R; Fiorentini G; Malaguti C; Picci P; Rosito P; Campanacci M
    Chemioterapia; 1988 Apr; 7(2):138-42. PubMed ID: 3165058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
    Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
    Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous necrosis in osteosarcoma.
    Springfield DS; Schakel ME; Spanier SS
    Clin Orthop Relat Res; 1991 Feb; (263):233-7. PubMed ID: 1993380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy].
    Spina V; Torricelli P; Manfrini M; Picci P; Romagnoli R
    Radiol Med; 1993 Jun; 85(6):725-32. PubMed ID: 8337428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
    Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
    Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvis and extremity osteosarcoma with similar tumor volume have an equivalent survival.
    Song WS; Cho WH; Jeon DG; Kong CB; Kim MS; Lee JA; Eid AS; Kim JD; Lee SY
    J Surg Oncol; 2010 Jun; 101(7):611-7. PubMed ID: 20461769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results.
    Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A
    Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of extremity osteosarcoma in patients aged 40-60 years: a cohort/case controlled study at a single institute.
    Song WS; Kong CB; Jeon DG; Cho WH; Kim MS; Lee JA; Yoo JY; Kim JD; Lee SY
    Eur J Surg Oncol; 2010 May; 36(5):483-8. PubMed ID: 20363585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor.
    Bacci G; Bertoni F; Longhi A; Ferrari S; Forni C; Biagini R; Bacchini P; Donati D; Manfrini M; Bernini G; Lari S
    Cancer; 2003 Jun; 97(12):3068-75. PubMed ID: 12784343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ErbB2 expression is correlated with increased survival of patients with osteosarcoma.
    Akatsuka T; Wada T; Kokai Y; Kawaguchi S; Isu K; Yamashiro K; Yamashita T; Sawada N; Yamawaki S; Ishii S
    Cancer; 2002 Mar; 94(5):1397-404. PubMed ID: 11920494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
    Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
    Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
    Yuan D; Liu B; Liu K; Zhu G; Dai Z; Xie Y
    J Surg Oncol; 2013 Sep; 108(3):157-62. PubMed ID: 23813624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
    Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
    Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of multidrug resistance-associated protein 1 in osteosarcoma and its relationship with clinicopathologic characteristics].
    Tu C; Tian Y; Pei F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):684-7. PubMed ID: 14619581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-glycoprotein levels predict poor outcome in patients with osteosarcoma.
    Hornicek FJ; Gebhardt MC; Wolfe MW; Kharrazi FD; Takeshita H; Parekh SG; Zurakowski D; Mankin HJ
    Clin Orthop Relat Res; 2000 Apr; (373):11-7. PubMed ID: 10810457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.